Why it’s a good year for diagnostics startups
Venture capitalists have typically shied away from investing in diagnostics. That mentality has changed, and a GE Ventures executive explains why.
Illumina embarks on its own next-gen journey
With a new tumor profiling panel, Illumina continues its transformation from a research tools provider to a genetic healthcare company.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.